Dolby Laboratories, Inc. DLB Cash Flow Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $245.33M+1.3% | $242.1M-5.6% | $256.49M-3.5% | $265.7M+2.7% | $258.82M-2.3% | ||
| $92.17M+2.9% | $89.61M+2.0% | $87.83M+0.7% | $87.19M+4.3% | $83.57M+4.4% | ||
| $129.7M0.0% | $129.66M+0.9% | $128.51M+1.1% | $127.14M+1.1% | $125.75M+1.4% | ||
| $13.94M+13.2% | $12.31M+147% | $4.99M+139% | -$12.75M+31.4% | -$18.57M+21.0% | ||
| $4.31M+62.9% | $2.64M+2.4% | $2.58M— | —— | —— | ||
| $122.13M— | —— | —— | —— | —— | ||
| -$13.03M-72.4% | -$7.56M+5.7% | -$8.02M— | —— | —— | ||
| $78.46M+27.3% | $61.62M+170% | $22.85M— | —— | —— | ||
| —— | —— | —— | -$37.43M-518% | $8.96M+259% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $8.07M+250% | -$5.36M+14.1% | ||
| -$883K+54.5% | -$1.94M+61.8% | -$5.08M+33.3% | -$7.61M+16.4% | -$9.11M-84.7% | ||
| —— | —— | —— | —— | —— | ||
| $10.46M-1.3% | $10.6M-1.6% | $10.77M-4.0% | $11.22M-3.7% | $11.65M+1.1% | ||
| $8.21M+233% | -$6.15M+27.6% | -$8.5M+22.2% | -$10.92M+8.8% | -$11.97M-566% | ||
| —— | —— | —— | —— | $2.34M-3.8% | ||
| $337.83M-19.6% | $420.22M-11.0% | $472.2M+1.4% | $465.54M+11.1% | $419.11M-1.5% | ||
| $36.36M+6.3% | $34.2M-5.9% | $36.35M+32.3% | $27.48M-4.1% | $28.67M-6.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $245.52M+5.4% | ||
| —— | —— | —— | —— | —— | ||
| -$73.18M-5,999% | -$1.2M+88.7% | -$10.59M+95.8% | -$249.98M+0.5% | -$251.3M+14.8% | ||
| $131.9M+1.9% | $129.39M+2.2% | $126.6M+2.4% | $123.62M+2.4% | $120.69M+2.6% | ||
| $240.01M+14.3% | $210.01M+35.5% | $155.01M+10.7% | $140.01M+33.3% | $105M+10.5% | ||
| $32.87M-8.2% | $35.79M-18.1% | $43.7M+10.9% | $39.4M+6.5% | $36.98M-16.1% | ||
| $1.97M+19.2% | $1.65M-10.4% | $1.85M-12.3% | $2.11M-58.7% | $5.1M+5.0% | ||
| -$346.51M-11.2% | -$311.5M-26.0% | -$247.24M-1.6% | -$243.3M-1.0% | -$240.96M-9.4% | ||
| —— | —— | —— | —— | —— | ||
| -$76.54M-166% | $115.91M-46.2% | $215.61M+1,077% | -$22.06M+70.2% | -$74.01M+23.7% | ||
| $73.84M-1.3% | $74.77M+1.4% | $73.74M+3.9% | $70.97M+4.1% | $68.19M+9.9% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | $2.34M-3.8% | ||
| $10.93M+154% | -$20.27M-21.5% | -$16.68M-339% | $6.97M— | —— | ||
| $8.21M+233% | -$6.15M+27.6% | -$8.5M+22.2% | -$10.92M+8.8% | -$11.97M-566% | ||
| $20.07M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$37.43M-518% | $8.96M+259% | ||
| $10.46M-1.3% | $10.6M-1.6% | $10.77M-4.0% | $11.22M-3.7% | $11.65M+1.1% | ||
| —— | —— | —— | $8.07M+250% | -$5.36M+14.1% | ||
| $4.31M+62.9% | $2.64M+2.4% | $2.58M— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $245.52M+5.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $261K+33.3% | $195.75K+50.0% | $130.5K+100% | ||
| —— | —— | $0+100% | -$180.5K+50.0% | -$361K+33.3% | ||
| $35.51M-1.3% | $35.99M-3.3% | $37.24M+1.2% | $36.8M-0.5% | $36.97M0.0% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | —— | $0+100% | -$2.48M+50.0% | -$4.96M+33.3% | ||
| —— | —— | $1.24M-52.2% | $2.59M-34.3% | $3.94M-25.5% | ||
| $8.21M+233% | -$6.15M+27.6% | -$8.5M+22.2% | -$10.92M+8.8% | -$11.97M-566% | ||
| -$533K+77.6% | -$2.38M+16.0% | -$2.83M-121% | $13.3M— | —— | ||
| —— | —— | $0— | $0— | $0— | ||
| $301.47M-21.9% | $386.02M-11.4% | $435.85M-0.5% | $438.05M+12.2% | $390.44M-1.1% | ||
| $301.47M-21.9% | $386.02M-11.4% | $435.85M-0.5% | $438.05M+12.2% | $390.44M-1.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Dolby Laboratories, Inc.'s cash flow data come from?
- Every line is extracted from Dolby Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.